Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Becky Kinkead

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cancer|October 19, 2017
Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trialBecky Kinkead, Pamela J Schettler, Erika R Larson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 14, 2020
Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammationStefania Lamon-Fava, Jisun So, David Mischoulon, et al.
Epilepsy & Behavior : E&B|December 10, 2019
Differential antiseizure medication sensitivity of the Affective Reactivity Index: A randomized controlled trial in new-onset pediatric focal epilepsyDavid W Loring, Kimford J Meador, Shlomo Shinnar, et al.
Biological Psychiatry|August 11, 2017
Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress DisorderBoadie W Dunlop, Elisabeth B Binder, Dan Iosifescu, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 4, 2011
A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trialSanjay J Mathew, Meena Vythilingam, James W Murrough, et al.
Trials|June 22, 2014
Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trialBoadie W Dunlop, Barbara O Rothbaum, Elisabeth B Binder, et al.
The Journal of Clinical Psychiatry|August 25, 2022
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical TrialDavid Mischoulon, Boadie W Dunlop, Becky Kinkead, et al.
Trials|July 11, 2012
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trialBoadie W Dunlop, Elisabeth B Binder, Joseph F Cubells, et al.
Translational Psychiatry|February 2, 2021
Combined effects of genotype and childhood adversity shape variability of DNA methylation across ageDarina Czamara, Elleke Tissink, Johanna Tuhkanen, et al.
Molecular Psychiatry|October 9, 2019
Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestryTim B Bigdeli, Giulio Genovese, Penelope Georgakopoulos, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cancer|October 19, 2017
Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trialBecky Kinkead, Pamela J Schettler, Erika R Larson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 14, 2020
Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammationStefania Lamon-Fava, Jisun So, David Mischoulon, et al.
Epilepsy & Behavior : E&B|December 10, 2019
Differential antiseizure medication sensitivity of the Affective Reactivity Index: A randomized controlled trial in new-onset pediatric focal epilepsyDavid W Loring, Kimford J Meador, Shlomo Shinnar, et al.
Biological Psychiatry|August 11, 2017
Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress DisorderBoadie W Dunlop, Elisabeth B Binder, Dan Iosifescu, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 4, 2011
A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trialSanjay J Mathew, Meena Vythilingam, James W Murrough, et al.
Trials|June 22, 2014
Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trialBoadie W Dunlop, Barbara O Rothbaum, Elisabeth B Binder, et al.
The Journal of Clinical Psychiatry|August 25, 2022
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical TrialDavid Mischoulon, Boadie W Dunlop, Becky Kinkead, et al.
Trials|July 11, 2012
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trialBoadie W Dunlop, Elisabeth B Binder, Joseph F Cubells, et al.
Translational Psychiatry|February 2, 2021
Combined effects of genotype and childhood adversity shape variability of DNA methylation across ageDarina Czamara, Elleke Tissink, Johanna Tuhkanen, et al.
Molecular Psychiatry|October 9, 2019
Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestryTim B Bigdeli, Giulio Genovese, Penelope Georgakopoulos, et al.
Pageof 5